<?xml version="1.0" encoding="UTF-8"?>
<p>The antibiofilm activities of some EOs, namely eugenol, carvacrol, or copaiba oil [
 <xref rid="B31-pharmaceutics-13-00631" ref-type="bibr">31</xref>,
 <xref rid="B32-pharmaceutics-13-00631" ref-type="bibr">32</xref>], against a large spectrum of pathogenic bacterial strains, and their isolated components, were recently investigated and reviewed [
 <xref rid="B33-pharmaceutics-13-00631" ref-type="bibr">33</xref>]. The review by Barros presented a suggestive illustration of the mechanisms, by which the nano-formulations and nanoparticles conjugated with natural products could affect bacterial biofilms (
 <xref ref-type="fig" rid="pharmaceutics-13-00631-f001">Figure 1</xref>).
</p>
